Successful Retreatment of HCV Genotype-1 Infected Patients Who Failed Prior Therapy With Peginterferon plus Ribavirin Plus 1 or 2 Other Direct-Acting Antiviral Agents With Sofosbuvir

被引：0
|
作者：
Jacobson, Ira M.
Sulkowski, Mark
Hassanein, Tarek
Ni, Liyun
Mo, Hongmei
Kanwar, Bittoo
Brainard, Diana M.
Subramanian, G. M.
Symonds, William T.
McHutchison, John G.
Bennett, Michael T.
Gane, Edward
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
237
引用
收藏
页码：S904 / S904
页数：1
相关论文
共 50 条
  • [31] Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2
    Ohya, Kazuki
    Akuta, Norio
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kominami, Yoko
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (05) : 919 - 925
  • [32] Sustained virologic response with daclatasvir plus sofosbuvir ± ribavirin (RBV) in chronic HCV genotype (GT) 1-infected patients who previously failed telaprevir (TVR) or boceprevir (BOC)
    Sulkowski, M. S.
    Gardiner, D. F.
    Rodriguez-Torres, M.
    Reddy, K. R.
    Hassanein, T.
    Jacobson, I.
    Lawitz, E.
    Lok, A. S.
    Hinestrosa, F.
    Thuluvath, P. J.
    Schwartz, H.
    Nelson, D. R.
    Everson, G. T.
    Eley, T.
    Wind-Rotolo, M.
    Huang, S. P.
    Gao, M.
    Mcphee, F.
    Hernandez, D.
    Sherman, D.
    Hindes, R.
    Symonds, W.
    Pasquinelli, C.
    Grasela, D. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 155 - 155
  • [33] SUSTAINED VIROLOGIC RESPONSE WITH DACLATASVIR PLUS SOFOSBUVIR ± RIBAVIRIN (RBV) IN CHRONIC HCV GENOTYPE (GT) 1-INFECTED PATIENTS WHO PREVIOUSLY FAILED TELAPREVIR (TVR) OR BOCEPREVIR (BOC)
    Sulkowski, M. S.
    Gardiner, D. F.
    Rodriguez-Torres, M.
    Reddy, K. R.
    Hassanein, T.
    Jacobson, I.
    Lawitz, E.
    Lok, A. S.
    Hinestrosa, F.
    Thuluvath, P. J.
    Schwartz, H.
    Nelson, D. R.
    Everson, G. T.
    Eley, T.
    Wind-Rotolo, M.
    Huang, S. -P.
    Gao, M.
    McPhee, F.
    Hernandez, D.
    Sherman, D.
    Hindes, R.
    Symonds, W.
    Pasquinelli, C.
    Grasela, D. M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S570 - S570
  • [34] Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients
    Tsubota, Akihito
    Shimada, Noritomo
    Yoshizawa, Kai
    Furihata, Tomomi
    Agata, Rie
    Yumoto, Yoko
    Abe, Hiroshi
    Ika, Makiko
    Namiki, Yoshihisa
    Chiba, Kan
    Fujise, Kiyotaka
    Tada, Norio
    Aizawa, Yoshio
    LIVER INTERNATIONAL, 2012, 32 (05) : 826 - 836
  • [35] Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naive patients in China and South Korea
    Wei, Lai
    Han, Tao
    Yang, Dongliang
    Heo, Jeong
    Shang, Jia
    Cheng, Jun
    Chen, Xinyue
    Xie, Qing
    Kim, Ju-Hyun
    Kalmeijer, Ronald
    Ouwerkerk-Mahadevan, Sivi
    Hoeben, Eva
    Lenz, Oliver
    Verbinnen, Thierry
    Sinha, Rekha
    Li, MengChun
    Scott, Jane
    Peeters, Monika
    Witek, James
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 912 - 920
  • [36] All-Oral Therapy With Sofosbuvir Plus Ribavirin For the Treatment of HCV Genotype 1, 2, and 3 Infection in Patients Co-infected With HIV (PHOTON-1)
    Sulkowski, Mark S.
    Rodriguez-Torres, Maribel
    Lalezari, Jacob P.
    Fessel, W. Jeffrey
    Mounzer, Karam
    Shuhart, Margaret C.
    Luetkemeyer, Anne
    Asmuth, David M.
    Gaggar, Anuj
    Symonds, William T.
    McHutchison, John G.
    Naggie, Susanna
    Dieterich, Douglas T.
    HEPATOLOGY, 2013, 58 : 313A - 314A
  • [37] Sofosbuvir-Velpatasvir-Voxilaprevir With or Without Ribavirin in Direct-Acting Antiviral-Experienced Patients With Genotype 1 Hepatitis C Virus
    Lawitz, Eric
    Poordad, Fred
    Wells, Jennifer
    Hyland, Robert H.
    Yang, Yin
    Dvory-Sobol, Hadas
    Stamm, Luisa M.
    Brainard, Diana M.
    McHutchison, John G.
    Landaverde, Carmen
    Gutierrez, Julio
    HEPATOLOGY, 2017, 65 (06) : 1803 - 1809
  • [38] Hepatocellular carcinoma development in Japanese patients with HCV genotype 1 infection who achieved sustained virologic response by ledipasvir/sofosbuvir and protease inhibitor with peginterferon plus ribavirin
    Korenaga, Masaaki
    Izumi, Namiki
    Yokosuka, Osamu
    Takehara, Tetsuo
    Sakamoto, Naoya
    Nishiguchi, Shuhei
    Ikeda, Fusao
    Yanase, Mikio
    Toyoda, Hidenori
    Genda, Takuya
    Umemura, Takeji
    Yatsuhashi, Hiroshi
    Ide, Tatsuya
    Toda, Nobuo
    Nirei, Kazushige
    Ueno, Yoshiyuki
    Nishigaki, Yoichi
    Nakane, Kunio
    Kanto, Tatsuya
    Omata, Masao
    Mizokami, Masashi
    HEPATOLOGY, 2017, 66 : 563A - 564A
  • [39] Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
    Hsieh, Meng-Hsuan
    Yeh, Ming-Lun
    Su, Tung-Hung
    Liu, Ta-Wei
    Huang, Chuang-Feng
    Huang, Ching-I.
    Wang, Shu-Chi
    Huang, Jee-Fu
    Dai, Chia-Yen
    Kao, Jia-Horng
    Chuang, Wan-Long
    Chen, Pei-Jer
    Liu, Chun-Jen
    Yu, Ming-Lung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (06) : 497 - 504
  • [40] Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings
    Chen, Cheng-Pin
    Cheng, Chien-Yu
    Zou, Huachun
    Cheng, Chun-Han
    Cheng, Shu-Hsing
    Chen, Cheng-Kuo
    Chen, Ching-Hsiang
    Bair, Ming-Jong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (04) : 556 - 562
12345